{"id":995352,"date":"2026-08-14T07:31:37","date_gmt":"2026-08-14T11:31:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/"},"modified":"2026-08-14T07:31:37","modified_gmt":"2026-08-14T11:31:37","slug":"evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/","title":{"rendered":"Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p class=\"prntac\">Zoom conference call scheduled for August 18, 2026, at 9:00 AM ET<\/p>\n<p>\n        <span class=\"legendSpanClass\">REHOVOT, Israel<\/span>, <span class=\"legendSpanClass\">Aug. 14, 2026<\/span> \/PRNewswire\/ &#8212; Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that its Chairman, Nir Nimrodi, will join the Company&#8217;s upcoming quarterly results conference call on\u00a0August 18, 2026.\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <img decoding=\"async\" src=\"https:\/\/mmx.prnewswire.com\/media\/MS1751115\/Evogene-Logo.jpg?id=OA2884728\" title=\"Evogene Logo\" alt=\"Evogene Logo\" \/>\n        <\/p>\n<\/p><\/div>\n<p>Mr. Nimrodi will address the current situation involving certain dissident shareholders. Mr. Nimrodi will discuss the Company&#8217;s perspective on these developments and the potential implications of those dissidents&#8217; attempted actions for Evogene and its shareholders.\u00a0<\/p>\n<p>The conference call is scheduled for Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time).<\/p>\n<p>To attend the conference, please register in advance:\u00a0<br \/><a href=\"https:\/\/protect.checkpoint.com\/v2\/r02\/___https:\/www.veidan-conferencing.com\/evogene___.YzJlOm1laXRhcmxhdzpjOm9mZmljZTM2NV9lbWFpbHNfYXR0YWNobWVudDo0N2FmNzg3OTU4ZTQ3YjU1ZWUxNmY5NGI2ZTdmZjJhMTo3OmQyYTI6NThmOGE4ZTFiNmNmMjZlN2JlZmFjMWNiZGY2ZjU1OGEzMjJkZmVmMmMzNDM4ZjJjNDAxYmUzNTViYzMxMmI3ZDpwOkY6Rg\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.veidan-conferencing.com\/evogene<\/a><\/p>\n<p>The entire conference will be available online on the Company&#8217;s website a few days after the call.<\/p>\n<p>\n        <b>About Evogene:<\/b>\n      <\/p>\n<p>Evogene Ltd.\u00a0(Nasdaq\/TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for drug development and ag chemical products. At the core of its technology is <i>ChemPass AI\u2122<\/i>, a proprietary generative AI designed to explore vast chemical space and generate novel, highly potent small molecules optimized across multiple critical parameters.\u00a0Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products for the pharmaceutical and agricultural industries, driven by the integration of scientific innovation with real-world industry needs.<\/p>\n<p>For more information, please visit <a href=\"https:\/\/www.evogene.com\/\" target=\"_blank\" rel=\"nofollow\">www.evogene.com<\/a>.<\/p>\n<p>\n        <b>Contact\u00a0<br \/><\/b><br \/>\n        <a href=\"mailto:ir@evogene.com\" target=\"_blank\" rel=\"nofollow\">ir@evogene.com<\/a><br \/>\n        <br \/>Tel: +972-8-9311901<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LN26193&amp;sd=2026-08-14\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation-302851346.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation-302851346.html<\/a><\/p>\n<p>SOURCE Evogene<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LN26193&amp;Transmission_Id=202608140700PR_NEWS_USPR_____LN26193&amp;DateId=20260814\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Zoom conference call scheduled for August 18, 2026, at 9:00 AM ET REHOVOT, Israel, Aug. 14, 2026 \/PRNewswire\/ &#8212; Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that its Chairman, Nir Nimrodi, will join the Company&#8217;s upcoming quarterly results conference call on\u00a0August 18, 2026.\u00a0 Mr. Nimrodi will address the current situation involving certain dissident shareholders. Mr. Nimrodi will discuss the Company&#8217;s perspective on these developments and the potential implications of those dissidents&#8217; attempted actions for Evogene and its shareholders.\u00a0 The conference call is scheduled for Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time). &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-995352","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Zoom conference call scheduled for August 18, 2026, at 9:00 AM ET REHOVOT, Israel, Aug. 14, 2026 \/PRNewswire\/ &#8212; Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that its Chairman, Nir Nimrodi, will join the Company&#8217;s upcoming quarterly results conference call on\u00a0August 18, 2026.\u00a0 Mr. Nimrodi will address the current situation involving certain dissident shareholders. Mr. Nimrodi will discuss the Company&#8217;s perspective on these developments and the potential implications of those dissidents&#8217; attempted actions for Evogene and its shareholders.\u00a0 The conference call is scheduled for Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time). &hellip; Continue reading &quot;Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-14T11:31:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mmx.prnewswire.com\/media\/MS1751115\/Evogene-Logo.jpg?id=OA2884728\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation\",\"datePublished\":\"2026-08-14T11:31:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\\\/\"},\"wordCount\":283,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1751115\\\/Evogene-Logo.jpg?id=OA2884728\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\\\/\",\"name\":\"Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1751115\\\/Evogene-Logo.jpg?id=OA2884728\",\"datePublished\":\"2026-08-14T11:31:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1751115\\\/Evogene-Logo.jpg?id=OA2884728\",\"contentUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1751115\\\/Evogene-Logo.jpg?id=OA2884728\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/","og_locale":"en_US","og_type":"article","og_title":"Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation - Market Newsdesk","og_description":"PR Newswire Zoom conference call scheduled for August 18, 2026, at 9:00 AM ET REHOVOT, Israel, Aug. 14, 2026 \/PRNewswire\/ &#8212; Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that its Chairman, Nir Nimrodi, will join the Company&#8217;s upcoming quarterly results conference call on\u00a0August 18, 2026.\u00a0 Mr. Nimrodi will address the current situation involving certain dissident shareholders. Mr. Nimrodi will discuss the Company&#8217;s perspective on these developments and the potential implications of those dissidents&#8217; attempted actions for Evogene and its shareholders.\u00a0 The conference call is scheduled for Tuesday, August 18, 2026, at 9:00 AM Eastern Time (4:00 PM Israel time). &hellip; Continue reading \"Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-14T11:31:37+00:00","og_image":[{"url":"https:\/\/mmx.prnewswire.com\/media\/MS1751115\/Evogene-Logo.jpg?id=OA2884728","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation","datePublished":"2026-08-14T11:31:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/"},"wordCount":283,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1751115\/Evogene-Logo.jpg?id=OA2884728","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/","name":"Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1751115\/Evogene-Logo.jpg?id=OA2884728","datePublished":"2026-08-14T11:31:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/#primaryimage","url":"https:\/\/mmx.prnewswire.com\/media\/MS1751115\/Evogene-Logo.jpg?id=OA2884728","contentUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1751115\/Evogene-Logo.jpg?id=OA2884728"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-chairman-nir-nimrodi-to-join-quarterly-results-call-to-address-current-dissident-shareholders-situation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/995352","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=995352"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/995352\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=995352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=995352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=995352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}